Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatments used in patients with MGMID
| Treatment | No. of patients (% of patients), n = 27 |
|---|---|
| None | 6 (22%) |
| RAS blockade alone | 6 (22%) |
| Steroids and calcineurin inhibitor | 4 (15%) |
| Steroids and mycophenolate | 7 (26%) |
| Steroids and plaquenil | 1 (4%) |
| Steroids, calcineurin inhibitor, and rituximab | 1 (4%) |
| Steroids and azathioprine | 1 (4%) |
| Rituximab alone | 1 (4%) |
MGMID, membranous-like glomerulopathy with masked IgG κ deposits; RAS, renin−angiotensin system.
